Pesquisas alternativas:
campos carl » campos carlos (Expandir a Pesquisa)
aida campos » avila campos (Expandir a Pesquisa), lidia campos (Expandir a Pesquisa), magda campos (Expandir a Pesquisa)
carl anton » karl anton (Expandir a Pesquisa), carr anton (Expandir a Pesquisa), scharl anton (Expandir a Pesquisa)
comme la » comme les (Expandir a Pesquisa), comme _ (Expandir a Pesquisa)
l comme » la comme (Expandir a Pesquisa), ele comme (Expandir a Pesquisa), las comme (Expandir a Pesquisa)
e aida » de aida (Expandir a Pesquisa), e ainda (Expandir a Pesquisa), e aids (Expandir a Pesquisa)
3 nucl » 3 null (Expandir a Pesquisa)
nucl n » nucl eng (Expandir a Pesquisa)
n than » n thao (Expandir a Pesquisa), n thin (Expandir a Pesquisa)
campos carl » campos carlos (Expandir a Pesquisa)
aida campos » avila campos (Expandir a Pesquisa), lidia campos (Expandir a Pesquisa), magda campos (Expandir a Pesquisa)
carl anton » karl anton (Expandir a Pesquisa), carr anton (Expandir a Pesquisa), scharl anton (Expandir a Pesquisa)
comme la » comme les (Expandir a Pesquisa), comme _ (Expandir a Pesquisa)
l comme » la comme (Expandir a Pesquisa), ele comme (Expandir a Pesquisa), las comme (Expandir a Pesquisa)
e aida » de aida (Expandir a Pesquisa), e ainda (Expandir a Pesquisa), e aids (Expandir a Pesquisa)
3 nucl » 3 null (Expandir a Pesquisa)
nucl n » nucl eng (Expandir a Pesquisa)
n than » n thao (Expandir a Pesquisa), n thin (Expandir a Pesquisa)
41
Por Salomon, Thibault, Nganoa, Catherine, Gac, Anne-Claire, Fruchart, Christophe, Damaj, Gandhi, Aide, Nicolas, Lasnon, Charline
Publicado no Eur J Nucl Med Mol Imaging (2017)
“...(max), all DS4 steatotic patients on interim (n = 1) and EoT (n = 2) PET moved to DS3. CONCLUSIONS...”Publicado no Eur J Nucl Med Mol Imaging (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
42
“... into three groups according to age: young group (<45 years, n=83), middle group (45–54 years, n=80), and old...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
43
Por Nishii, Ryuichi, Higashi, Tatsuya, Kagawa, Shinya, Kishibe, Yoshihiko, Takahashi, Masaaki, Yamauchi, Hiroshi, Motoyama, Hideki, Kawakami, Kenzo, Nakaoku, Takashi, Nohara, Jun, Okamura, Misato, Watanabe, Toshiki, Nakatani, Koichi, Nagamachi, Shigeki, Tamura, Shozo, Kawai, Keiichi, Kobayashi, Masato
Publicado em 2013
“...: n = 2, sarcoidosis: n = 15, non-specific inflammation: n = 18, other inflammatory: n = 4...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
44
Por Zhang, Hanwen, Huang, Ruimin, Pillarsetty, NagaVaraKishore, Thorek, Daniel LJ, Vaidyanathan, Ganesan, Serganova, Inna, Blasberg, Ronald G., Lewis, Jason S.
Publicado em 2013
“... were synthesized manually using a 3-step synthetic scheme. Wild-type and hNET reporter gene-transduced...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
45
Por Arsanjani, Reza, Xu, Yuan, Dey, Damini, Fish, Matthews, Dorbala, Sharmila, Hayes, Sean, Berman, Daniel, Germano, Guido, Slomka, Piotr
Publicado em 2013
“... perfusion and functional variables for non-corrected (NC) data by support vector machines (SVM), a computer...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
46
Por Keiding, Susanne, Sørensen, Michael, Frisch, Kim, Gormsen, Lars C, Munk, Ole Lajord
Publicado no Am J Nucl Med Mol Imaging (2018)
“.../min/mL liver tissue) greater than the hepatic blood perfusion. We developed a new microvascular...”Publicado no Am J Nucl Med Mol Imaging (2018)
Obter o texto integral
Obter o texto integral
Artigo
47
Por Shin, I. S., Lee, S.-M., Kim, H. S., Yao, Z., Regino, C., Sato, N., Cheng, K. T., Hassan, R., Campo, M. F., Albone, E. F., Choyke, P. L., Pastan, I., Paik, C. H.
Publicado em 2011
“... the optimal level of CHX-A″ conjugation, CHX-A″-MORAb-009 conjugates with 2.4, 3.5, and 5.5 CHX-A″ molecules...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
48
Por Bradbury, Michelle S., Hambardzumyan, Dolores, Zanzonico, Pat B., Schwartz, Jazmin, Cai, Shangde, Burnazi, Eva M., Longo, Valerie, Larson, Steven M., Holland, Eric C.
Publicado em 2008
“... in glioma-bearing mice (n = 10) and in non–tumor-bearing control mice (n = 4) by use of a dedicated small...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
49
Por Chitneni, Satish K., Bida, Gerald T., Yuan, Hong, Palmer, Gregory M., Hay, Michael P., Melcher, Thorsten, Wilson, William R., Zalutsky, Michael R., Dewhirst, Mark W.
Publicado em 2013
“... the usefulness of 2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-(18)F-pentafluoropropyl)-acetamide ((18)F-EF5) PET...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
50
Por Kasten, Benjamin B., Gangrade, Abhishek, Kim, Harrison, Fan, Jinda, Ferrone, Soldano, Ferrone, Cristina R., Zinn, Kurt R., Buchsbaum, Donald J.
Publicado no Nucl Med Biol (2017)
“... to human PDAC3 adherent differentiated cells and non-adherent cancer initiating cells (CICs) dissociated...”Publicado no Nucl Med Biol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
51
Por Hong, Hao, Severin, Gregory W., Yang, Yunan, Engle, Jonathan W., Zhang, Yin, Barnhart, Todd E., Liu, Glenn, Leigh, Bryan R., Nickles, Robert J., Cai, Weibo
Publicado em 2011
“...-injection respectively (n = 4), higher than all organs starting from 24 h post-injection, which provided...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
52
Por Wilson, George H., Gore, John C., Yankeelov, Thomas E., Barnes, Stephanie, Peterson, Todd E., True, Jarrod M., Shokouhi, Sepideh, McIntyre, J. Oliver., Sanders, Melinda, Abramson, Vandana, Ngyuen, The-Quyen, Mahadevan-Jansen, Anita, Tantawy, Mohammed N.
Publicado no J Nucl Med (2014)
“... while type II have been shown to be produced, internally, by malignant cells. No current non-invasive...”Publicado no J Nucl Med (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
53
Por Nguyen, Xuan Canh, Nguyen, Van Khoi, Tran, Minh Thong, Maurea, Simone, Salvatore, Marco
Publicado em 2014
“... non-small cell lung cancer (NSCLC). Eighty-three patients (49 male, 34 female) with advanced NSCLC...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
54
“...) lost their α(v)β(3) integrin receptor binding affinity by greater than 248-fold or MC1 receptor binding...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
55
Por Keramida, Georgia, Dunford, Alexander, Kaya, Guven, Anagnostopoulos, Constantinos D, Peters, Adrien Michael
Publicado no Am J Nucl Med Mol Imaging (2018)
“.... Splenic MRglu was higher in patients with hepatic steatosis (4.0±1.6; n = 12) than without (2.6±1.7 μmol...”Publicado no Am J Nucl Med Mol Imaging (2018)
Obter o texto integral
Obter o texto integral
Artigo
56
Por Yang, Hsin-Jung, Dey, Damini, Sykes, Jane, Klein, Michael, Butler, John, Kovacs, Michael S., Sobczyk, Olivia, Sharif, Behzad, Bi, Xiaoming, Kali, Avinash, Cokic, Ivan, Tang, Richard, Yumul, Roya, Conte, Antonio H., Tsaftaris, Sotirios A., Tighiouart, Mourad, Li, Debiao, Slomka, Piotr J., Berman, Daniel S., Prato, Frank S., Fisher, Joseph A., Dharmakumar, Rohan
Publicado no J Nucl Med (2017)
“.../g; these were significantly higher than at rest (0.9 ± 0.5 mL/min/g, P < 0.05) and were...”Publicado no J Nucl Med (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
57
Por Gupta, Manoj, Datta, Anupama, Choudhury, Partha S., Dsouza, Maria, Batra, Ullas, Mishra, Anil
Publicado no World J Nucl Med (2017)
“... (sensitivity 75.32%) and this difference was statistically significant. For nonhepatic lesions (n = 136...”Publicado no World J Nucl Med (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
58
Por Giesel, Frederik L., Hadaschik, B., Cardinale, J., Radtke, J., Vinsensia, M., Lehnert, W., Kesch, C., Tolstov, Y., Singer, S., Grabe, N., Duensing, S., Schäfer, M., Neels, O. C., Mier, W., Haberkorn, U., Kopka, K., Kratochwil, C.
Publicado no Eur J Nucl Med Mol Imaging (2016)
“...-DCFPyL and with slightly slower clearance kinetics than PSMA-11, favorable tumor-to-background ratios...”Publicado no Eur J Nucl Med Mol Imaging (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
59
Por Kim, Heejung, Lee, Sung-Jin, Davies-Venn, Cynthia, Kim, Jin Su, Yang, Bo Yeun, Yao, Zhengsheng, Kim, Insook, Paik, Chang H., Bluemke, David A.
Publicado no Nucl Med Commun (2016)
“... was labeled with (64)Cu-acetate. CD rats (n = 5) with MI by LAD ligation and normal rats (n = 6) were injected...”Publicado no Nucl Med Commun (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
60
Por Chen, Ron, Parry, Jesse J., Akers, Walter J., Berezin, Mikhail Y., El Naqa, Issam M., Achilefu, Samuel, Edwards, W. Barry, Rogers, Buck E.
Publicado em 2010
“...-Tyr3-octreotate was not significantly different (P > 0.05) when tumors (n = 5) were injected...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo